Most sold healthcare stocks in Q2 2016
See which Healthcare stocks institutional investors trimmed or exited the most in Q2 2016, measured as net reductions in reported share positions from Q1 2016 into Q2 2016. Notable reductions at the top of this list include ZOETIS INC (ZTS), ABBOTT LABORATORIES (ABT), TEVA PHARMACEUTICAL-SP ADR (TEVA), WALGREENS BOOTS ALLIANCE INC (WBA). These rankings aggregate SEC 13F filings from all institutional investors in our database.
Explore more:
| Symbol | Name | Net shares | Net value | New | Added | Trimmed | Sold out | Holding now |
|---|---|---|---|---|---|---|---|---|
| ZTS | ZOETIS INC | -21,068,448 | -$834.79M | 0 | 1 | 3 | 0 | 6 |
| ABT | ABBOTT LABORATORIES | -7,957,433 | -$363.95M | 1 | 3 | 3 | 4 | 8 |
| TEVA | TEVA PHARMACEUTICAL-SP ADR | -6,949,262 | -$468.74M | 0 | 2 | 3 | 0 | 5 |
| WBA | WALGREENS BOOTS ALLIANCE INC | -5,535,106 | -$473.85M | 1 | 1 | 3 | 2 | 9 |
| PFE | PFIZER INC | -4,889,704 | -$73.72M | 1 | 5 | 8 | 2 | 15 |
| ELV | ELEVANCE HEALTH INC | -3,403,549 | -$552.87M | 0 | 4 | 2 | 1 | 7 |
| DHR | DANAHER CORP | -3,086,179 | -$187.61M | 0 | 1 | 5 | 0 | 9 |
| JNJ | JOHNSON & JOHNSON | -2,880,547 | -$13.01M | 1 | 7 | 10 | 0 | 23 |
| AMGN | AMGEN INC | -2,461,297 | -$369.53M | 2 | 2 | 2 | 1 | 9 |
| INVA | INNOVIVA INC | -2,076,092 | -$69.33M | 0 | 1 | 1 | 0 | 2 |
| LLY | ELI LILLY & CO | -1,771,813 | -$26.05M | 1 | 2 | 3 | 0 | 7 |
| BAX | BAXTER INTERNATIONAL INC | -1,757,163 | $196.91M | 1 | 3 | 4 | 1 | 8 |
| ILMN | ILLUMINA INC | -1,675,158 | -$271.57M | 0 | 0 | 0 | 1 | 1 |
| BDX | BECTON DICKINSON AND CO | -1,506,657 | -$145.07M | 1 | 2 | 7 | 0 | 10 |
| HOLX | HOLOGIC INC | -1,130,418 | -$38.89M | 1 | 0 | 1 | 1 | 2 |
| EXEL | EXELIXIS INC | -1,008,919 | -$4.04M | 0 | 0 | 0 | 1 | 0 |
| A | AGILENT TECHNOLOGIES INC | -978,824 | -$2.69M | 1 | 0 | 3 | 0 | 5 |
| DXCM | DEXCOM INC | -962,626 | -$61.47M | 0 | 0 | 1 | 1 | 1 |
| UNH | UNITEDHEALTH GROUP INC | -855,319 | $204.32M | 0 | 2 | 7 | 0 | 10 |
| PTCT | PTC THERAPEUTICS INC | -846,800 | -$5.39M | 0 | 0 | 1 | 0 | 1 |
| BMRN | BIOMARIN PHARMACEUTICAL INC | -818,007 | -$69.17M | 0 | 0 | 1 | 2 | 1 |
| PACB | PACIFIC BIOSCIENCES OF CALIF | -784,636 | -$7.26M | 0 | 0 | 1 | 0 | 1 |
| SGMO | SANGAMO THERAPEUTICS INC | -709,591 | -$4.34M | 0 | 0 | 2 | 0 | 2 |
| UHS | UNIVERSAL HEALTH SERVICES-B | -545,022 | -$68.69M | 0 | 1 | 2 | 1 | 3 |
| PHG | KONINKLIJKE PHILIPS NVR- NY | -499,155 | -$50.98M | 0 | 1 | 2 | 0 | 3 |
| BKD | BROOKDALE SENIOR LIVING INC | -494,672 | -$8.92M | 0 | 0 | 1 | 1 | 1 |
| RMD | RESMED INC | -494,400 | -$24.32M | 0 | 0 | 1 | 0 | 1 |
| WST | WEST PHARMACEUTICAL SERVICES | -468,300 | -$32.16M | 0 | 0 | 1 | 0 | 1 |
| OMI | OWENS & MINOR INC | -410,421 | -$17.95M | 0 | 1 | 0 | 1 | 1 |
| EDIT | EDITAS MEDICINE INC | -403,818 | -$31.51M | 1 | 0 | 1 | 0 | 2 |
| CMRX | CHIMERIX INC | -375,123 | -$2.23M | 0 | 0 | 1 | 0 | 1 |
| NVS | NOVARTIS AG-SPONSORED ADR | -367,951 | $482.99M | 0 | 3 | 3 | 0 | 9 |
| COR | CENCORA INC | -356,474 | -$37.24M | 2 | 0 | 0 | 1 | 2 |
| THC | TENET HEALTHCARE CORP | -348,405 | -$10.08M | 0 | 0 | 0 | 1 | 0 |
| CRL | CHARLES RIVER LABORATORIES | -341,310 | -$10.97M | 0 | 1 | 2 | 0 | 3 |
| INCY | INCYTE CORP | -325,666 | -$20.28M | 0 | 0 | 2 | 0 | 2 |
| DGX | QUEST DIAGNOSTICS INC | -292,559 | -$16.38M | 0 | 0 | 1 | 0 | 1 |
| HCA | HCA HEALTHCARE INC | -292,501 | -$25.93M | 2 | 0 | 1 | 0 | 4 |
| BCRX | BIOCRYST PHARMACEUTICALS INC | -292,221 | -$827.00K | 0 | 0 | 0 | 1 | 0 |
| ATR | APTARGROUP INC | -287,200 | -$22.37M | 0 | 0 | 1 | 0 | 2 |
| CNC | CENTENE CORP | -284,326 | -$10.75M | 1 | 0 | 1 | 0 | 2 |
| SYK | STRYKER CORP | -279,296 | $69.32M | 0 | 1 | 4 | 0 | 5 |
| VNDA | VANDA PHARMACEUTICALS INC | -265,850 | -$1.79M | 0 | 0 | 1 | 0 | 1 |
| SNN | SMITH & NEPHEW PLC -SPON ADR | -261,200 | -$7.85M | 0 | 0 | 1 | 0 | 1 |
| EVH | EVOLENT HEALTH INC - A | -259,100 | -$2.74M | 0 | 0 | 0 | 1 | 0 |
| GMED | GLOBUS MEDICAL INC - A | -242,000 | -$5.74M | 0 | 0 | 1 | 0 | 1 |
| CYH | COMMUNITY HEALTH SYSTEMS INC | -235,933 | -$62.94M | 1 | 1 | 1 | 1 | 3 |
| ITCI | INTRA-CELLULAR THERAPIES INC | -233,900 | -$6.50M | 0 | 0 | 0 | 1 | 0 |
| ACHC | ACADIA HEALTHCARE CO INC | -215,285 | -$11.85M | 0 | 0 | 1 | 0 | 1 |
| EXAS | EXACT SCIENCES CORP | -210,100 | -$1.42M | 0 | 0 | 0 | 1 | 0 |
Frequently asked questions about Most sold healthcare stocks in Q2 2016
What are the most sold Healthcare stocks in Q2 2016?
The most sold healthcare stocks in Q2 2016 are those with the largest decrease in reported share counts across institutional investors compared to Q1 2016, based on SEC 13F filings.
Which healthcare stocks did institutional investors trimmed or exited the most in Q2 2016?
Among filers in this sector, net reductions were largest in companies such as ZOETIS INC (ZTS), ABBOTT LABORATORIES (ABT), TEVA PHARMACEUTICAL-SP ADR (TEVA), based on aggregated 13F data.
How is institutional selling calculated?
Selling is calculated by summing the net decrease in shares reported by institutional investors between two consecutive quarterly 13F snapshots (compared to Q1 2016).
Does this include all institutional owners?
Yes. These rankings aggregate SEC 13F filings from all institutional investors in our database, not only the investors we track individually.
Are these trades real-time?
No. 13F filings are reported quarterly and may be delayed by up to 45 days. The data reflects positions at the end of the reporting period, not real-time trading activity.